Oxford Immunotec (OXFD) PT Raised to $24 at Piper Sandler
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts OXFD Hot Sheet
Price: $21.99 --0%
Rating Summary:
3 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 4 | New: 5
Rating Summary:
3 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 4 | New: 5
Join SI Premium – FREE
Piper Sandler analyst Steven Mah raised the price target on Oxford Immunotec (NASDAQ: OXFD) to $24.00 (from $18.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Deutsche Bank Downgrades J Sainsbury PLC (SBRY:LN) (JSNSF) to Hold
- Genmab A/S (GEN:DC) (GMAB) PT Raised to DKK3,500 at Deutsche Bank
- Sartorius AG (SRT3:GR) (SARTF) PT Raised to EUR325 at Deutsche Bank
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
